From: Shear wave elastography in chronic kidney disease: a pilot experience in native kidneys
 | CKD (n = 25) | Control (n = 20) |
---|---|---|
Age (years) | 61 (56, 70) | 34 (29, 49) |
Male Gender | 16 (64Â %) | 5 (25Â %) |
Ethnicitya | Â | Â |
    Non-Hispanic | 20 (83 %) | 18 (90 %) |
    Hispanic | 4 (17 %) | 2 (10 %) |
Race | Â | Â |
    White | 20 (80 %) | 15 (75 %) |
    Other | 5 (20 %) | 5 (25 %) |
Height (cm) | 170.2 (163.0, 177.8) | 165.0 (162.8, 169.0) |
Weight (kg) | 76.0 (71.0, 88.0) | 65.8 (61.1, 69.0) |
BMI (kg/m2) | 26.1 (24.8, 28.4) | 23.4 (22.1, 24.0) |
Kidney Length (cm) b | 10.35 (9.16, 10.95) | 10.47 (10.10, 11.07) |
Kidney Depth to Region of Interest (cm) | 3.60 (1.64, 5.56) | 3.15 (2.45, 3.85) |
Hematocritc | 38.2 (33.6, 40.2) | 40.8 (39.6, 41.1) |
BUN (mg/dL) d | 30 (18, 38) | 13 (11, 15) |
Creatinine (mg/dL) d | 1.74 (1.42, 2.38) | 0.90 (0.79, 0.96) |
GFR (mL/min) | 38 (28, 42) | >60 |
CKD Stage | Â | Â |
    CKD Stage 1-2 | 1 (4 %) |  |
    CKD Stage 3 | 17 (68 %) |  |
    CKD Stage 4 | 5 (20 %) |  |
    CKD Stage 5 | 2 (8 %) |  |
Cause of CKD | Â | Â |
    Diabetes/Hypertension | 13 (52 %) |  |
    IgA Nephropathy | 3 (12 %) |  |
    Renovascular Disease | 1 (4 %) |  |
    Other Known Diagnosis | 6 (24 %) |  |
    Unknown Diagnosis | 2 (8 %) |  |
Other Medical History | Â | Â |
    Hypertension | 24 (96 %) |  |
    Hyperlipidemia | 18 (72 %) |  |
    Diabetes | 7 (28 %) |  |
    Gout | 5 (20 %) |  |
    Coronary Artery Disease | 5 (20 %) |  |
    Congestive Heart Failure | 5 (20 %) |  |
    Vascular Disease | 4 (16 %) |  |
    Hypothyroidism | 4 (16 %) |  |
    Prostatic Hypertrophy | 3 (12 %) |  |